Lexeo Therapeutics (LXEO) News Today $13.42 -1.13 (-7.77%) (As of 12/29/2023 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineLexeo Therapeutics, Inc. (NASDAQ:LXEO) Given Average Rating of "Buy" by Brokeragesamericanbankingnews.com - December 25 at 4:18 AMLexeo gets orphan drug, fast track status for cardiac gene therapyseekingalpha.com - December 19 at 7:16 PMLexeo Therapeutics Says FDA Grants Fast Track And Orphan Drug Designation To LX2020markets.businessinsider.com - December 18 at 7:42 AMLexeo Therapeutics Granted FDA Fast Track Designation and Orphan Drug Designation for LX2020, an AAV-Based Gene Therapy Candidate for PKP2 Arrhythmogenic Cardiomyopathy (ACM)finance.yahoo.com - December 18 at 7:42 AMLeerink Partnrs Weighs in on Lexeo Therapeutics, Inc.'s FY2023 Earnings (NASDAQ:LXEO)marketbeat.com - December 14 at 6:48 AMStable Execution and Positive Clinical Progress Support $19 Price Target for Lexeo Therapeuticsmarkets.businessinsider.com - December 14 at 1:07 AMLexeo Therapeutics Inc (LXEO) Reports Q3 2023 Financial Results and Advances Clinical Programsfinance.yahoo.com - December 13 at 9:56 AMLexeo Therapeutics Reports Third Quarter 2023 Financial Results and Operational Highlightsfinance.yahoo.com - December 11 at 11:59 AMLexeo Therapeutics Inc LXEOmorningstar.com - December 8 at 3:54 PMmarketbeat.com - November 8 at 9:33 AM Get Lexeo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LXEO and its competitors with MarketBeat's FREE daily newsletter. Email Address LXEO Media Mentions By Week LXEO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LXEO News Sentiment▼1.610.84▲Average Medical News Sentiment LXEO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LXEO Articles This Week▼21▲LXEO Articles Average Week Get Lexeo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LXEO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Voyager Therapeutics News Today Fate Therapeutics News Today iTeos Therapeutics News Today Orchard Therapeutics News Today Coherus BioSciences News Today ProKidney News Today Aura Biosciences News Today Invivyd News Today Cullinan Oncology News Today Taysha Gene Therapies News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:LXEO) was last updated on 12/31/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lexeo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.